Accueil
Envoyer à un ami
Imprimer
Grand
Petit
Partager
ACTUALITES

Novartis International AG - Novartis data show more than 50 percent of eligible Ph+ CML patients maintain Treatment-free Remission (TFR) after stopping Tasigna?


- 4 Juin 2016 modifié le 1 Janvier 1970


Novartis International AG / Novartis data show more than 50 percent of eligible Ph+ CML patients maintain Treatment-free Remission (TFR) after stopping Tasigna? . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely...

Source : http://www.romandie.com/news/Novartis-Internationa...


ACTUALITES | INTERNATIONAL | TCHAD | POLITIQUE | CULTURE | EXCLUSIF | Revue de Presse | English News | 中國